Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Diabetes Care
|
November 10, 2010
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
Robert J Anderson, Gideon D Bahn, Thomas E Moritz, et al.
Diabetes Care
|
September 25, 2019
Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT)
Lily Agrawal, Nasrin Azad, Gideon D Bahn, et al.
Diabetes Care
|
October 9, 2013
Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)
Nasrin Azad, Lily Agrawal, Nicholas V Emanuele, et al.
Diabetes Care
|
July 22, 2011
Observation on renal outcomes in the Veterans Affairs Diabetes Trial
Lily Agrawal, Nasrin Azad, Nicholas V Emanuele, et al.
Diabetes Care
|
March 24, 2016
Association of Blood Glucose Control and Lipids With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)
Nasrin Azad, Gideon D Bahn, Nicholas V Emanuele, et al.
Diabetologia
|
November 5, 2017
Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
Lily Agrawal, Nasrin Azad, Gideon D Bahn, et al.
American Journal of Preventive Cardiology
|
May 27, 2024
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial
Leah E Cahill, Rachel A Warren, Gideon D Bahn, et al.
The New England Journal of Medicine
|
June 6, 2019
Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up
Peter D Reaven, Nicholas V Emanuele, Wyndy L Wiitala, et al.
Clinical Therapeutics
|
February 4, 2014
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers
Samuel S Dychter, Rena Harrigan, Jesse D Bahn, et al.
The New England Journal of Medicine
|
June 4, 2015
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Diabetes Care
|
November 10, 2010
Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial
Robert J Anderson, Gideon D Bahn, Thomas E Moritz, et al.
Diabetes Care
|
September 25, 2019
Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT)
Lily Agrawal, Nasrin Azad, Gideon D Bahn, et al.
Diabetes Care
|
October 9, 2013
Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)
Nasrin Azad, Lily Agrawal, Nicholas V Emanuele, et al.
Diabetes Care
|
July 22, 2011
Observation on renal outcomes in the Veterans Affairs Diabetes Trial
Lily Agrawal, Nasrin Azad, Nicholas V Emanuele, et al.
Diabetes Care
|
March 24, 2016
Association of Blood Glucose Control and Lipids With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)
Nasrin Azad, Gideon D Bahn, Nicholas V Emanuele, et al.
Diabetologia
|
November 5, 2017
Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
Lily Agrawal, Nasrin Azad, Gideon D Bahn, et al.
American Journal of Preventive Cardiology
|
May 27, 2024
Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial
Leah E Cahill, Rachel A Warren, Gideon D Bahn, et al.
The New England Journal of Medicine
|
June 6, 2019
Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up
Peter D Reaven, Nicholas V Emanuele, Wyndy L Wiitala, et al.
Clinical Therapeutics
|
February 4, 2014
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers
Samuel S Dychter, Rena Harrigan, Jesse D Bahn, et al.
The New England Journal of Medicine
|
June 4, 2015
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, et al.
Page
of 2